What is the primary purpose of initiating treatment with Tikosyn?

The primary purpose of initiating treatment with Tikosyn, which contains the active ingredient dofetilide, is to restore normal heart rhythm. Tikosyn is classified as an antiarrhythmic medication primarily used to treat atrial fibrillation and atrial flutter. These conditions are characterized by an irregular and often rapid heart rhythm that can lead to symptoms such as palpitations, shortness of breath, and fatigue.

By restoring normal rhythm, Tikosyn helps improve the heart's efficiency and decreases the risk of potential complications associated with irregular heartbeats, such as strokes and other heart-related issues. Although it is true that managing heart failure symptoms can be an ancillary benefit of achieving a more stable heart rhythm, the main goal of initiating therapy with Tikosyn is explicitly focused on correcting the arrhythmia.

The other choices, while relevant to heart health, do not specifically pertain to the primary action of Tikosyn. Reducing blood pressure is more aligned with antihypertensive medications, and while Tikosyn may have some effect on hypertrophy through improved rhythm and function, this is not its designated purpose.